Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
Zacks' 7 Best Stocks
for June, 2013
FREE Report for Zacks.com
Visitors Only
Visitors Only
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
- Latest News
- Most Popular
- Hitting Home Runs & Grand Slams, Not Loud Outs
- RTI: Do Stocks Tank When QE Ends?
- 3 Top-Ranked Consumer ETFs to Buy Now
- This Week's Aggressive Growth Stocks
- Who Wants to Keep "Too Big to Fail" Alive?
- Debt-Ceiling Alarm Bell Tolls
- Avoid These 3 Eurozone ETFs This Summer
- RTI: When Will We Finally See a Pullback?
- Top Stocks with Big Potential Catch-Up Moves
- PFP 5/23: Do No Harm
- AWS 5/22: Will Bernanke Show His Hand?
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 05/22/2013
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 9.31% |
| SONIC FOUNDR | SOFO | 7.77% |
| VELTI PLC | VELT | 7.58% |
| TRI-TECH HOL | TRIT | 6.62% |
| AMR CORP | AAMRQ | 4.52% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Arch Chemicals, which has global operations, produces chemicals that destroy and control the growth of harmful microbes. It has two segments: Biocides Products and Performance Products. It's largest segment is the Biocides.
The company focuses on water treatment including sanitizers and chemicals that destroy microbes in pools and spas, drinking water and water used in industrial and commercial uses such as bottle cleaning operations.
Arch Had Record Earnings in 2010
On Feb 3, Arch reported fourth quarter results and surprised on the Zacks Consensus Estimate for the 6th quarter in a row.
Earnings per share were 20 cents compared to the consensus of just 1 cent. The company earned 12 cents in the year ago quarter.
Sales rose to $311.7 million from $293.4 million last year. The gains were due to higher sales from innovative products and emerging markets. Its largest segment, Biocides, saw sales rise 5.4% to $263.9 million.
Outlook for 2011
2011 is shaping up to be another strong year. Arch projects sales to rise between 5% to 7% due to strong growth from the Biocides business.
Since the earnings report, analysts have been raising estimates for 2011 and 2012.
The 2011 Zacks Consensus Estimate has jumped to $2.84 from $2.60 in the last week. That is earnings growth of 6.9%.
Analysts expect another 6.1% earnings growth in 2012 with the consensus moving to $3.02 from $2.77 in the last 7 days.
Attractive Valuations
In addition to the low P/E ratio, Arch has a price-to-book of 2 which is well within the value parameters.
It also has a price-to-sales ratio of just 0.7.
Arch Chemicals is a Zacks #1 Rank (strong buy) stock.
Read the Sep 9, 2010 article.
This Week's Value Zacks Rank Buy Stocks
Specialty chemical companies are bullish about 2011 as global demand continues to recover. Cabot Corporation (CBT) is growing its emerging markets business to tap into that demand. Cabot is a value stock, trading with a forward P/E of 14. Read the full article.
The global technology and industrial recovery has been strong the last few quarters. Newport Corporation (NEWP) recently reported record 4th quarter sales as all of its end markets saw strong demand. Even with shares surging, the stock is cheap, trading at just 12.9x forward estimates. Read the full article.
One thing is clear from this earnings season. Those companies with a global reach, especially in chemicals and industrial materials, have fully rebounded from pre-recession levels. PolyOne Corporation (POL) just reported a record 2010 as earnings rose 252% and sales jumped 27%. Read the full article.
ScanSource Inc. (SCSC) blew by the Zacks Consensus Estimate when it reported fiscal second quarter results on Jan 27 in yet another example that the global recovery is on the fast track. This Zacks #1 Rank (strong buy) is trading at just 14.3x forward estimates. Read the full article.
Tracey Ryniec is the Value Stock Strategist for Zacks.com. She is also the Editor in charge of the market-beating Zacks Value Trader service. You can follow her at twitter.com/traceyryniec.